Cargando…
Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study
OBJECTIVES: The aim of this study was to investigate the association of serum fibrinogen with cardiovascular events (CVE) in Chinese patients with type 2 diabetes mellitus (T2DM) and stable coronary artery disease (CAD). DESIGN: An observational study. SETTING: FuWai Hospital in Beijing, China. PART...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734258/ https://www.ncbi.nlm.nih.gov/pubmed/28601829 http://dx.doi.org/10.1136/bmjopen-2016-015041 |
_version_ | 1783287028011499520 |
---|---|
author | Yang, Sheng-Hua Du, Ying Zhang, Yan Li, Xiao-Lin Li, Sha Xu, Rui-Xia Zhu, Cheng-Gang Guo, Yuan-Lin Wu, Na-Qiong Qing, Ping Gao, Ying Cui, Chuan-Jue Dong, Qian Sun, Jing Li, Jian-Jun |
author_facet | Yang, Sheng-Hua Du, Ying Zhang, Yan Li, Xiao-Lin Li, Sha Xu, Rui-Xia Zhu, Cheng-Gang Guo, Yuan-Lin Wu, Na-Qiong Qing, Ping Gao, Ying Cui, Chuan-Jue Dong, Qian Sun, Jing Li, Jian-Jun |
author_sort | Yang, Sheng-Hua |
collection | PubMed |
description | OBJECTIVES: The aim of this study was to investigate the association of serum fibrinogen with cardiovascular events (CVE) in Chinese patients with type 2 diabetes mellitus (T2DM) and stable coronary artery disease (CAD). DESIGN: An observational study. SETTING: FuWai Hospital in Beijing, China. PARTICIPANTS: A cohort of 1466 patients with T2DM and angiographic-proven stable CAD was evaluated. OUTCOME MEASURES: Baseline serum fibrinogen levels were measured and trisected into ‘low’, ‘middle’ and ‘high’. Their association with CVE was explored using Cox proportional hazard models. RESULTS: With 20.2 months (average) follow-up, 44 (3%) were lost to follow-up and 96 patients developed CVE. Compared with the patients without CVE, the ones who developed CVE had higher levels of fibrinogen. Univariable regression revealed a significant relation of fibrinogen to CVE (HR (HR) 1.25, 95% CI 1.06 to 1.47, p=0.010) per SD increase of fibrinogen at baseline. After adjusting for multiple established cardiovascular disease (CVD) risk factors, the association persisted (HR 1.30, 95% CI 1.02 to 1.66, p=0.037). Moreover, after adjusting for CVD risk factors, the HRs for middle-serum and high-serum fibrinogen concentration, using ‘low’ group as reference, were 1.23 (95% CI 0.69 to 2.20) and 2.20 (95% CI 1.11 to 3.36, p=0.049). CONCLUSIONS: We first indicated that elevated fibrinogen level was independently associated with increased CVE in Chinese patients with T2DMand stable CAD. |
format | Online Article Text |
id | pubmed-5734258 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-57342582017-12-20 Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study Yang, Sheng-Hua Du, Ying Zhang, Yan Li, Xiao-Lin Li, Sha Xu, Rui-Xia Zhu, Cheng-Gang Guo, Yuan-Lin Wu, Na-Qiong Qing, Ping Gao, Ying Cui, Chuan-Jue Dong, Qian Sun, Jing Li, Jian-Jun BMJ Open Cardiovascular Medicine OBJECTIVES: The aim of this study was to investigate the association of serum fibrinogen with cardiovascular events (CVE) in Chinese patients with type 2 diabetes mellitus (T2DM) and stable coronary artery disease (CAD). DESIGN: An observational study. SETTING: FuWai Hospital in Beijing, China. PARTICIPANTS: A cohort of 1466 patients with T2DM and angiographic-proven stable CAD was evaluated. OUTCOME MEASURES: Baseline serum fibrinogen levels were measured and trisected into ‘low’, ‘middle’ and ‘high’. Their association with CVE was explored using Cox proportional hazard models. RESULTS: With 20.2 months (average) follow-up, 44 (3%) were lost to follow-up and 96 patients developed CVE. Compared with the patients without CVE, the ones who developed CVE had higher levels of fibrinogen. Univariable regression revealed a significant relation of fibrinogen to CVE (HR (HR) 1.25, 95% CI 1.06 to 1.47, p=0.010) per SD increase of fibrinogen at baseline. After adjusting for multiple established cardiovascular disease (CVD) risk factors, the association persisted (HR 1.30, 95% CI 1.02 to 1.66, p=0.037). Moreover, after adjusting for CVD risk factors, the HRs for middle-serum and high-serum fibrinogen concentration, using ‘low’ group as reference, were 1.23 (95% CI 0.69 to 2.20) and 2.20 (95% CI 1.11 to 3.36, p=0.049). CONCLUSIONS: We first indicated that elevated fibrinogen level was independently associated with increased CVE in Chinese patients with T2DMand stable CAD. BMJ Publishing Group 2017-06-09 /pmc/articles/PMC5734258/ /pubmed/28601829 http://dx.doi.org/10.1136/bmjopen-2016-015041 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Cardiovascular Medicine Yang, Sheng-Hua Du, Ying Zhang, Yan Li, Xiao-Lin Li, Sha Xu, Rui-Xia Zhu, Cheng-Gang Guo, Yuan-Lin Wu, Na-Qiong Qing, Ping Gao, Ying Cui, Chuan-Jue Dong, Qian Sun, Jing Li, Jian-Jun Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study |
title | Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study |
title_full | Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study |
title_fullStr | Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study |
title_full_unstemmed | Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study |
title_short | Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study |
title_sort | serum fibrinogen and cardiovascular events in chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734258/ https://www.ncbi.nlm.nih.gov/pubmed/28601829 http://dx.doi.org/10.1136/bmjopen-2016-015041 |
work_keys_str_mv | AT yangshenghua serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy AT duying serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy AT zhangyan serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy AT lixiaolin serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy AT lisha serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy AT xuruixia serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy AT zhuchenggang serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy AT guoyuanlin serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy AT wunaqiong serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy AT qingping serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy AT gaoying serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy AT cuichuanjue serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy AT dongqian serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy AT sunjing serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy AT lijianjun serumfibrinogenandcardiovasculareventsinchinesepatientswithtype2diabetesandstablecoronaryarterydiseaseaprospectiveobservationalstudy |